ACCURAY INCORPORATED (NASDAQ:ARAY) Files An 8-K Regulation FD Disclosure

ACCURAY INCORPORATED (NASDAQ:ARAY) Files An 8-K Regulation FD Disclosure
Item 7.01. Regulation FD Disclosure.

Story continues below

Representatives of Accuray Incorporated (the “Company”) intend to present the management presentation slides, attached hereto as Exhibit99.1, during a conference from January8-10, 2018. Such slides may be used in additional presentations to investors and analysts from time to time. The management presentation slides will also be posted on the investor relations portion of the Company’s website.

The information contained in this Current Report on Form8-K, including Exhibit99.1, is furnished to Item 7.01 and shall not be deemed to be “filed” for the purposes of Section18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section, nor shall it be incorporated by reference into a filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.




Management Presenation Slides of Accuray Incorporated, Dated January10, 2018.

EX-99.1 2 a18-2387_1ex99d1.htm EX-99.1 Exhibit 99.1 36th Annual J.P. Morgan Healthcare Conference January 10,…
To view the full exhibit click here


Accuray Incorporated is a radiation oncology company. The Company develops, manufactures and markets medical devices used in radiation therapy for the treatment of cancer patients. Its products include the CyberKnife Systems, the TomoTherapy Systems, and the Radixact Delivery Treatment Platform. Its technologies, the CyberKnife and TomoTherapy Systems, are designed to deliver treatments, including stereotactic radiosurgery (SRS), stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), image guided radiation therapy (IGRT) and adaptive radiation therapy. The CyberKnife Systems are robotic systems that are used to treat various types of cancer and tumors throughout the body. The CyberKnife Systems track, detect and correct for tumor and patient movement in real-time during the procedure. The TomoTherapy Systems include the TomoTherapy H Series with configuration options of TomoH, TomoHD and TomoHDA.

An ad to help with our costs